620.80
-2.30%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Solara Active Pharma Sciences Ltd. is trading above its 150 day SMA of 574.5
More from Solara Active Pharma Sciences Ltd.
Recommended